vs
Apellis Pharmaceuticals, Inc.（APLS）与LINDBLAD EXPEDITIONS HOLDINGS, INC.（LIND）财务数据对比。点击上方公司名可切换其他公司
Apellis Pharmaceuticals, Inc.的季度营收约是LINDBLAD EXPEDITIONS HOLDINGS, INC.的1.1倍（$199.9M vs $183.2M），LINDBLAD EXPEDITIONS HOLDINGS, INC.净利率更高（-12.9% vs -29.5%，领先16.6%），LINDBLAD EXPEDITIONS HOLDINGS, INC.同比增速更快（23.3% vs -5.9%），LINDBLAD EXPEDITIONS HOLDINGS, INC.自由现金流更多（$3.5M vs $-14.3M），过去两年LINDBLAD EXPEDITIONS HOLDINGS, INC.的营收复合增速更高（9.2% vs 7.7%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
林德布拉德探险控股是一家专业探险旅行企业，总部位于美国纽约。目前公司运营15艘探险邮轮，载客量从28人到150人不等，可为旅行者提供覆盖全球七大洲目的地的探险邮轮旅程。
APLS vs LIND — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $183.2M |
| 净利润 | $-59.0M | $-23.6M |
| 毛利率 | — | 40.3% |
| 营业利润率 | -25.6% | -3.0% |
| 净利率 | -29.5% | -12.9% |
| 营收同比 | -5.9% | 23.3% |
| 净利润同比 | -62.2% | 6.0% |
| 每股收益（稀释后） | $-0.40 | $-0.45 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $199.9M | $183.2M | ||
| Q3 25 | $458.6M | $240.2M | ||
| Q2 25 | $178.5M | $167.9M | ||
| Q1 25 | $166.8M | $179.7M | ||
| Q4 24 | $212.5M | $148.6M | ||
| Q3 24 | $196.8M | $206.0M | ||
| Q2 24 | $199.7M | $136.5M | ||
| Q1 24 | $172.3M | $153.6M |
| Q4 25 | $-59.0M | $-23.6M | ||
| Q3 25 | $215.7M | $1.2M | ||
| Q2 25 | $-42.2M | $-8.5M | ||
| Q1 25 | $-92.2M | $1.2M | ||
| Q4 24 | $-36.4M | $-25.0M | ||
| Q3 24 | $-57.4M | $22.5M | ||
| Q2 24 | $-37.7M | $-24.7M | ||
| Q1 24 | $-66.4M | $-4.0M |
| Q4 25 | — | 40.3% | ||
| Q3 25 | — | 48.2% | ||
| Q2 25 | — | 45.6% | ||
| Q1 25 | — | 48.3% | ||
| Q4 24 | — | 42.5% | ||
| Q3 24 | — | 46.7% | ||
| Q2 24 | — | 39.2% | ||
| Q1 24 | — | 45.0% |
| Q4 25 | -25.6% | -3.0% | ||
| Q3 25 | 48.7% | 15.0% | ||
| Q2 25 | -18.6% | 2.6% | ||
| Q1 25 | -50.0% | 5.9% | ||
| Q4 24 | -12.3% | -5.1% | ||
| Q3 24 | -24.0% | 14.3% | ||
| Q2 24 | -14.7% | -6.0% | ||
| Q1 24 | -36.0% | 5.1% |
| Q4 25 | -29.5% | -12.9% | ||
| Q3 25 | 47.0% | 0.5% | ||
| Q2 25 | -23.6% | -5.1% | ||
| Q1 25 | -55.3% | 0.6% | ||
| Q4 24 | -17.1% | -16.9% | ||
| Q3 24 | -29.2% | 10.9% | ||
| Q2 24 | -18.9% | -18.1% | ||
| Q1 24 | -38.5% | -2.6% |
| Q4 25 | $-0.40 | $-0.45 | ||
| Q3 25 | $1.67 | $0.00 | ||
| Q2 25 | $-0.33 | $-0.18 | ||
| Q1 25 | $-0.74 | $0.00 | ||
| Q4 24 | $-0.30 | $-0.45 | ||
| Q3 24 | $-0.46 | $0.36 | ||
| Q2 24 | $-0.30 | $-0.48 | ||
| Q1 24 | $-0.54 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $256.7M |
| 总债务越低越好 | — | $662.7M |
| 股东权益账面价值 | $370.1M | $-284.5M |
| 总资产 | $1.1B | $980.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $466.2M | $256.7M | ||
| Q3 25 | $479.2M | $261.8M | ||
| Q2 25 | $370.0M | $200.9M | ||
| Q1 25 | $358.4M | $188.9M | ||
| Q4 24 | $411.3M | $183.9M | ||
| Q3 24 | $396.9M | $193.9M | ||
| Q2 24 | $360.1M | $168.1M | ||
| Q1 24 | $325.9M | $177.7M |
| Q4 25 | — | $662.7M | ||
| Q3 25 | — | $663.5M | ||
| Q2 25 | — | $627.3M | ||
| Q1 25 | — | $626.4M | ||
| Q4 24 | — | $625.5M | ||
| Q3 24 | — | $624.5M | ||
| Q2 24 | — | $623.6M | ||
| Q1 24 | $93.1M | $622.7M |
| Q4 25 | $370.1M | $-284.5M | ||
| Q3 25 | $401.2M | $-256.6M | ||
| Q2 25 | $156.3M | $-263.8M | ||
| Q1 25 | $164.2M | $-252.2M | ||
| Q4 24 | $228.5M | $-253.1M | ||
| Q3 24 | $237.1M | $-226.9M | ||
| Q2 24 | $264.3M | $-255.5M | ||
| Q1 24 | $266.7M | $-227.4M |
| Q4 25 | $1.1B | $980.0M | ||
| Q3 25 | $1.1B | $976.5M | ||
| Q2 25 | $821.4M | $936.5M | ||
| Q1 25 | $807.3M | $908.8M | ||
| Q4 24 | $885.1M | $876.9M | ||
| Q3 24 | $901.9M | $889.8M | ||
| Q2 24 | $904.5M | $858.3M | ||
| Q1 24 | $831.9M | $868.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.35× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $3.5M |
| 自由现金流率自由现金流/营收 | -7.1% | 1.9% |
| 资本支出强度资本支出/营收 | 0.1% | 6.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $45.0M | $63.8M |
8季度趋势，按日历期对齐
| Q4 25 | $-14.2M | $14.4M | ||
| Q3 25 | $108.5M | $19.5M | ||
| Q2 25 | $4.4M | $29.2M | ||
| Q1 25 | $-53.4M | $48.4M | ||
| Q4 24 | $19.4M | $1.7M | ||
| Q3 24 | $34.1M | $28.1M | ||
| Q2 24 | $-8.3M | $18.6M | ||
| Q1 24 | $-133.0M | $43.9M |
| Q4 25 | $-14.3M | $3.5M | ||
| Q3 25 | $108.3M | $11.9M | ||
| Q2 25 | $4.4M | $13.5M | ||
| Q1 25 | $-53.4M | $35.0M | ||
| Q4 24 | $19.3M | $-8.2M | ||
| Q3 24 | — | $18.4M | ||
| Q2 24 | $-8.4M | $11.2M | ||
| Q1 24 | $-133.3M | $37.4M |
| Q4 25 | -7.1% | 1.9% | ||
| Q3 25 | 23.6% | 5.0% | ||
| Q2 25 | 2.5% | 8.0% | ||
| Q1 25 | -32.0% | 19.5% | ||
| Q4 24 | 9.1% | -5.5% | ||
| Q3 24 | — | 8.9% | ||
| Q2 24 | -4.2% | 8.2% | ||
| Q1 24 | -77.3% | 24.4% |
| Q4 25 | 0.1% | 6.0% | ||
| Q3 25 | 0.0% | 3.2% | ||
| Q2 25 | 0.0% | 9.4% | ||
| Q1 25 | 0.0% | 7.5% | ||
| Q4 24 | 0.0% | 6.6% | ||
| Q3 24 | 0.0% | 4.7% | ||
| Q2 24 | 0.0% | 5.4% | ||
| Q1 24 | 0.2% | 4.2% |
| Q4 25 | — | — | ||
| Q3 25 | 0.50× | 16.41× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 41.69× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.25× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
LIND
| Guest Ticket | $96.5M | 53% |
| Landexperience | $67.3M | 37% |
| Other Tour | $19.4M | 11% |
